Novartis ($NVS), a leader among companies using the immune system…
https://cancure.com/wp-content/uploads/2015/05/Cancure_Logo_Website_v01.png00CAST ADMINhttps://cancure.com/wp-content/uploads/2015/05/Cancure_Logo_Website_v01.pngCAST ADMIN2015-03-30 12:45:132021-08-16 22:02:24Novartis tackles immuno-oncology with a $750M Aduro deal for new R&D group
